Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content
Diabetes PHGKB

Specific PHGKB|Diabetes PHGKB|Public Health Genomics and Precision Health Knowledge Base (PHGKB)

Last Posted: May 31, 2024
spot light Spotlight

Prediction of progression to type 1 diabetes with dynamic biomarkers and risk scores
(Posted May 26, 2024 11AM)

From the abstract: "Identifying biomarkers of functional ß-cell loss is an important step in the risk stratification of type 1 diabetes. Genetic risk scores (GRS), generated by profiling an array of single nucleotide polymorphisms, are a widely used type 1 diabetes risk-prediction tool. Type 1 diabetes screening studies have relied on a combination of biochemical (autoantibody) and GRS screening methodologies for identifying individuals at high-risk of type 1 diabetes. "

Equitable implementation of a precision digital health program for glucose management in individuals with newly diagnosed type 1 diabetes
(Posted May 03, 2024 5PM)

From the abstract: " Few young people with type 1 diabetes (T1D) meet glucose targets. Continuous glucose monitoring improves glycemia, but access is not equitable. We prospectively assessed the impact of a systematic and equitable digital-health-team-based care program implementing tighter glucose targets (HbA1c?<?7%), early technology use (continuous glucose monitoring starts <1?month after diagnosis) and remote patient monitoring on glycemia in young people with newly diagnosed T1D enrolled in the Teamwork, Targets, Technology, and Tight Control (4T Study)."

Polygenic scores for longitudinal prediction of incident type 2 diabetes in an ancestrally and medically diverse primary care physician network: a patient cohort study
(Posted Apr 29, 2024 11AM)

From the article: "Genetic information, if available, could improve T2D prediction among patients lacking measured clinical risk factors. Genome-wide association studies (GWAS) have identified hundreds of unique loci associated with T2D, the results of which can be used to calculate polygenic scores (PGS) that model genetic risk independently of established clinical risk factors including family history. Previous work has evaluated how PGS can be used within healthcare systems, but analyses have been largely cross-sectional in biobanks of mostly European ancestry, limiting the generalizability of results to a more ancestrally and medically diverse US healthcare system. "

Multi-ancestry polygenic mechanisms of type 2 diabetes
K Smith et al, Nature Medicine, March 6, 2024 (Posted Mar 06, 2024 9AM)

From the abstract: "Type 2 diabetes (T2D) is a multifactorial disease with substantial genetic risk, for which the underlying biological mechanisms are not fully understood. In this study, we identified multi-ancestry T2D genetic clusters by analyzing genetic data from diverse populations in 37 published T2D genome-wide association studies representing more than 1.4 million individuals. We implemented soft clustering with 650 T2D-associated genetic variants and 110 T2D-related traits, capturing known and novel T2D clusters with distinct cardiometabolic trait associations across two independent biobanks. "


news Latest News and Publications
Construction and validation of a covariate-based model for district-level estimation of excess deaths due to COVID-19 in India. External Web Site Icon
Krishnan Anand, et al. Journal of global health 2024 0 0. 05013
Review of the cost-effectiveness of surveillance for hereditary pancreatic cancer. External Web Site Icon
Louise Wang et al. Fam Cancer 2024
Predicting type 1 diabetes in children using electronic health records in primary care in the UK: development and validation of a machine-learning algorithm. External Web Site Icon
Rhian Daniel et al. Lancet Digit Health 2024 6(6) e386-e395
COVID-19 Vaccine: Predicting Vaccine Types and Assessing Mortality Risk Through Ensemble Learning Agorithms. External Web Site Icon
Monadhel Hind, et al. F1000Research 2024 0 0. 1200
COVID-19 mortality prediction in Hungarian ICU settings implementing random forest algorithm. External Web Site Icon
Hamar Ágoston, et al. Scientific reports 2024 0 0. (1) 11941
Apolipoprotein ɛ4 is associated with increased risk of fall- and fracture-related hospitalisation: the Perth Longitudinal Study of Ageing Women. External Web Site Icon
Jedd Pratt et al. J Gerontol A Biol Sci Med Sci 2024
Clinical Practice Guidelines for the Care of Girls and Women with Turner Syndrome. External Web Site Icon
Claus H Gravholt et al. Eur J Endocrinol 2024
Longitudinal artificial intelligence-based deep learning models for diagnosis and prediction of the future occurrence of polyneuropathy in diabetes and prediabetes. External Web Site Icon
Yun-Ru Lai et al. Neurophysiol Clin 2024 54(4) 102982
Machine Learning-Based Predictive Modeling of Diabetic Nephropathy in Type 2 Diabetes Using Integrated Biomarkers: A Single-Center Retrospective Study. External Web Site Icon
Ying Zhu et al. Diabetes Metab Syndr Obes 2024 171987-1997
Personalized prediction of diabetic foot ulcer recurrence in elderly individuals using machine learning paradigms. External Web Site Icon
Shichai Hong et al. Technol Health Care 2024

More


Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.

TOP